Glucose Transporter-1 Deficiency Syndrome: The Expanding Clinical and Genetic Spectrum of a Treatable Disorder
Brain 133:655-670, Leen,W.G., et al, 2010
Cerebrovascular Ischemic Events in Patients with Takayasu Arteritis
Stroke 53:1550-1557, Mirouse, A.,et al, 2022
Cerebrovascular Ischemic Events in Patients with Takayasu Arteritis
Stroke 53:1550-1557, Mirouse, A.,et al, 2022
MR Imaging of the Brain in Neurologic Wilson Disease
AJNR 40:178-183, Yu, X.-E.,et al, 2019
Clinical Manifestations of the anti-IgLON5 Disease
Neurol 88:1736-1743,1688, Gaig, C.,et al, 2017
Significant Period Between Presentation and Diagnosis in Basilar Artery Occlusion
Stroke 46:e79-e81, Organek, N.,et al, 2015
Dopa-Responsive Dystonia Revisited
Arch Neurol 69:1558-1562, Tadic, V.,et al, 2012
Atrial Myxoma
MedLink July, Muengtaweepongsa, S.,et al, 2011
Diagnosis and Management of the Antiphospholipid Syndrome
BMJ 340:1125-1132, Cohen,D., et al, 2010
Progressive Supranuclear Palsy: A Current Review
The Neurologist 14:79-88, Lubarsky,M. &Juncos,J.L., 2008
Wilson Disease: Description of 282 Patients Evaluated Over 3 Decades
Medicine 86:112-121, Taly,A.B., et al, 2007
Thrombosis of the Cerebral VEins and Sinuses
NEJM 352:1791-1798, Stam,J., 2005
Neonatal Brain Injury
NEJM 351:1985-1995, Ferriero,D.M., 2004
Takayasu Arteritis
Ann Int Med 120:919-929, Kerr,G.S.,et al, 1994